Correlation of Lobar Cerebral Microbleeds with Amyloid, Perfusion, and Metabolism in Alzheimer's Disease.
dc.contributor.author | Sheikh-Bahaei, Nasim | |
dc.contributor.author | Manavaki, Roido | |
dc.contributor.author | Sajjadi, S Ahmad | |
dc.contributor.author | Priest, Andrew N | |
dc.contributor.author | O'Brien, John T | |
dc.contributor.author | Gillard, Jonathan H | |
dc.contributor.orcid | Sheikh-Bahaei, Nasim [0000-0001-7029-7215] | |
dc.contributor.orcid | Manavaki, Roido [0000-0002-4384-6626] | |
dc.contributor.orcid | O'Brien, John [0000-0002-0837-5080] | |
dc.date.accessioned | 2019-04-11T23:30:16Z | |
dc.date.available | 2019-04-11T23:30:16Z | |
dc.date.issued | 2019 | |
dc.description.abstract | BACKGROUND: Despite the well-documented relationship between lobar cerebral microbleeds (lCMB) and Alzheimer's disease (AD), there is limited knowledge about the role of lCMB in AD pathology. OBJECTIVE: To understand the nature of this relationship, we investigated the association between lCMB, amyloid load, perfusion, and metabolism. METHODS: Participants with AD, mild cognitive impairment (MCI), and healthy controls were recruited and scanned with 11C-Pittsburg-Compound B (PiB), Fluorodeoxyglucose (FDG) PET, and susceptibility-weighted MRI. Early PiB-PET frames were used to estimate perfusion. The association between lCMB and PET uptake in each anatomical lobe was measured using multiple regression models. RESULTS: The presence of lCMB predicted increased total (p < 0.001) and regional (p = 0.0002) PiB uptake, as well as decreased cerebral perfusion (p = 0.03). Cases with lCMB had hypometabolism in their temporal lobe (p = 0.04). CONCLUSION: There are significant relationships between lCMBs and various markers of AD pathology. lCMB has a spatial association with Aβ load and a complex effect on perfusion and metabolism. | |
dc.format.medium | ||
dc.identifier.doi | 10.17863/CAM.38687 | |
dc.identifier.eissn | 1875-8908 | |
dc.identifier.issn | 1387-2877 | |
dc.identifier.uri | https://www.repository.cam.ac.uk/handle/1810/291527 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | IOS Press | |
dc.publisher.url | http://dx.doi.org/10.3233/jad-180443 | |
dc.rights | All rights reserved | |
dc.subject | Alzheimer’s disease | |
dc.subject | FDG-PET | |
dc.subject | PiB-PET | |
dc.subject | cerebral metabolism | |
dc.subject | cerebral perfusion | |
dc.subject | lobar cerebral microbleeds | |
dc.subject | susceptibility weighted imaging | |
dc.subject | Aged | |
dc.subject | Aged, 80 and over | |
dc.subject | Alzheimer Disease | |
dc.subject | Amyloid beta-Peptides | |
dc.subject | Brain | |
dc.subject | Cerebral Hemorrhage | |
dc.subject | Cognitive Dysfunction | |
dc.subject | Female | |
dc.subject | Fluorodeoxyglucose F18 | |
dc.subject | Humans | |
dc.subject | Magnetic Resonance Imaging | |
dc.subject | Male | |
dc.subject | Positron-Emission Tomography | |
dc.title | Correlation of Lobar Cerebral Microbleeds with Amyloid, Perfusion, and Metabolism in Alzheimer's Disease. | |
dc.type | Article | |
dcterms.dateAccepted | 2019-02-06 | |
prism.endingPage | 1497 | |
prism.issueIdentifier | 4 | |
prism.publicationDate | 2019 | |
prism.publicationName | J Alzheimers Dis | |
prism.startingPage | 1489 | |
prism.volume | 68 | |
pubs.funder-project-id | Cambridge University Hospitals NHS Foundation Trust (CUH) (unknown) | |
rioxxterms.licenseref.startdate | 2019-01 | |
rioxxterms.licenseref.uri | http://www.rioxx.net/licenses/all-rights-reserved | |
rioxxterms.type | Journal Article/Review | |
rioxxterms.version | AM | |
rioxxterms.versionofrecord | 10.3233/JAD-180443 |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- revised manuscript-V4-Final .docx
- Size:
- 148.34 KB
- Format:
- Microsoft Word XML
- Description:
- Accepted version
- Licence
- http://www.rioxx.net/licenses/all-rights-reserved
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- DepositLicenceAgreementv2.1.pdf
- Size:
- 150.9 KB
- Format:
- Adobe Portable Document Format